Zolpidem withdrawal delirium

Indian Journal of Pharmacology

Volumn 43, Issue 6, 2011, Pages 729-730

  Mattoo, Surendra K ^a   Gaur, Navendu ^a   Das, Partha P ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NorthWestern Mental Health   (Australia)

Author keywords

Adverse drug reactions; alcohol dependence; delirium; insomnia; zolpidem

Indexed keywords

DISULFIRAM; ESCITALOPRAM; HALOPERIDOL; LONG ACTING DRUG; LORAZEPAM; MIRTAZAPINE; PROPRANOLOL; ZOLPIDEM;

ADULT; AGITATION; ALCOHOLISM; BEDTIME DOSAGE; CASE REPORT; CONFERENCE PAPER; DELIRIUM; DETOXIFICATION; DISORIENTATION; DRUG DOSE REDUCTION; DYSTHYMIA; HAND TREMOR; HEPATOMEGALY; HUMAN; INSOMNIA; MALE; PRESCRIPTION; SCORING SYSTEM; SLEEP DISORDER;

EID: 81855217463     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.89838     Document Type: Conference Paper

References (10)

1. Toner LC, Tsambiras BM, Catalano G, Catalano MC, Cooper DS. Central nervous system side effects associated with zolpidem treatment. Clin Neuropharmacol 2000;23:54-8. (Pubitemid 30090414)
2. Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 2007;64:198-209. (Pubitemid 47063241)
3. Aggarwal A, Sharma DD. Zolpidem withdrawal delirium: a case report. J Neuropsychiatry Clin Neurosci 2010;22:451-o.e27-451.e28.
4. Trzepacz PT, Mittal D, Torres R, Kanary K, Norton J, Jimerson N. Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium. J Neuropsychiatry Clin Neurosci 2001;13:229-42. (Pubitemid 32499675)
5. Langtry HD, Benfield P. Zolpidem: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990;40:291-313.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4 th ed, Text Revision. Washington, DC: American Psychiatric Press; 2000.
7. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45. (Pubitemid 12149145)
8. Liappas IA, Malitas PN, Dimopoulos NP, Gitsa OE, Liappas AI, Nikolaou ChK, et al. Zolpidem dependence case series: possible neurobiological mechanisms and clinical management. J Psychopharmacol 2003;17:131-5. (Pubitemid 36373152)
9. Kumar S, Suryanarayanan A, Boyd KN, Comerford CE, Lai MA, Ren Q, et al. Ethanol reduces GABA(A) α1 subunit receptor surface expression by a PKCã dependent mechanism in cultured cerebral cortical neurons. Mol Pharmacol 2010;77:793-803.
10. Kovacic P, Somanathan R. Zolpidem, a clinical hypnotic that affects electronic transfer, alters synaptic activity through potential GABA receptors in the nervous system without significant free radical generation. Oxid Med Cell Longev 2009;2:52-7.